In Vivo. 2021 Mar-Apr;35(2):1117-1123. doi: 10.21873/invivo.12357.
ABSTRACT
AIM: To characterize a group of dogs diagnosed with meningioma or glioma treated with radiation therapy and assess the clinical impact of diagnosis and radiation protocol on survival time.
PATIENTS AND METHODS: Canine patient records from a single veterinary referral hospital, between 2011 and 2015, were searched for intracranial tumour cases treated with radiation therapy, as a sole modality. Thirty-two dogs were included.
RESULTS: Median survival times were 524 days [95% confidence interval (CI)=287-677] in total, 512 days (95% CI=101-682) for the glioma group and 536 days (95% CI=249-677) for the meningioma group. No significant difference in survival was detected when using a definitive or a palliative protocol (p=0.130), nor other prognostic factors were found.
CONCLUSION: Our results highlight the efficacy of radiation therapy in the tre atment of canine meningioma, as well as glioma, suggesting a change in the current perception of the response of glial tumours to radiation.
PMID:33622909 | DOI:10.21873/invivo.12357
No comments:
Post a Comment